Jose Mario Bello Pineda

Also affiliated with Stanford University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia”.

Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia

eLife(2021)10.7554/elife.65905

N/A

1.9DataRank · unranked

73 citations

Lauren Forbes, Masahiro Uni, Shuyuan Cheng, Jose Mario Bello Pineda, Yusuke Tarumoto +9 more

Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells

Nature Biotechnology(2022)10.1038/s41587-022-01224-2

N/A

0.626DataRank · unranked

64 citations

Salima Benbarche, Bo Liu, Joseph Pangallo, Sisi Chen, Maximilian Stahl +15 more

RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs

The Journal of Experimental Medicine(2025)10.1084/jem.20241029

N/A

0.345DataRank · unranked

9 citations

Anthony Glover, Brian R. Untch, Nickole Sigcha‐Coello, Bin Xu, Dina Vukel +15 more

DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers

eLife(2023)10.7554/elife.89017

N/A

0DataRank · unranked

13 citations

Robert K. Bradley, Jose Mario Bello Pineda

DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.10.548412

N/A

0DataRank · unranked

1 citations

Robert K. Bradley, Jose Mario Bello Pineda

DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers

(2023)10.7554/elife.89017.1

N/A

0DataRank · unranked

1 citations

Robert K. Bradley, Jose Mario Bello Pineda

GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignancies

Molecular Cell(2024)10.1016/j.molcel.2024.04.006

N/A

0DataRank · unranked

40 citations

Jose Mario Bello Pineda, Laura Baquero Galvis, Jeetayu Biswas, Bo Liu, Eric Wang +19 more

Large overlap in neutrophil transcriptome between lupus and COVID-19 with limited lupus-specific gene expression

Lupus Science & Medicine(2024)10.1136/lupus-2023-001059

N/A

0DataRank · unranked

5 citations

Noga Rogel, Jose Mario Bello Pineda, Xiaoxing Wang, Megan Tran, Alison Bays +2 more

Altered Protein Structures and Neoepitopes in Lupus Neutrophils From Dysregulated Splicing of Messenger RNA

ACR Open Rheumatology(2025)10.1002/acr2.11770

N/A

0DataRank · unranked

1 citations

Xiaoxing Wang, Jose Mario Bello Pineda, Hugh Alessi, Alison Bays, Robert K. Bradley +3 more

Chorionic Gonadotropin Beta 7 is a marker of immune evasion in cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.28.656535

N/A

0DataRank · unranked

1 citations

Jose Mario Bello Pineda, Rohan Lattupally, Amy Codd, Evan W. Newell, Sydney X. Lu +2 more

Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia

Cancer Cell(2022)10.1016/j.ccell.2022.12.002

N/A

0DataRank · unranked

78 citations

Jose Mario Bello Pineda, Won Jun Kim, Sisi Chen, Jessie Bourcier, Maximilian Stahl +22 more

The proto-oncogene SRC phosphorylates cGAS to inhibit an antitumor immune response

JCI Insight(2023)10.1172/jci.insight.167270

N/A

0DataRank · unranked

14 citations

Shivam A. Zaver, Jose Mario Bello Pineda, Cameron J. Howard, Robert K. Bradley, Joshua J. Woodward +1 more